Pascal Jézéquel

Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proof-of-concept, randomised, controlled phase 2 trial

Christophe Le Tourneau, Jean-Pierre Delord, Anthony Gonçalvès et al. · The Lancet Oncology · 2015 · 1.1K citations

Advanced Cancer, Drug Targeting, Oncology +12

bc-GenExMiner: an easy-to-use online platform for gene prognostic analyses in breast cancer

Pascal Jézéquel, Mario Campone, Wilfried Gouraud et al. · Breast Cancer Research and Treatment · 2011 · 425 citations

Prognostic Biomarkers, Breast Oncology, Engineering +13

Prediction of Survival in Multiple Myeloma Based on Gene Expression Profiles Reveals Cell Cycle and Chromosomal Instability Signatures in High-Risk Patients and Hyperdiploid Signatures in Low-Risk Patients: A Study of the Intergroupe Francophone du Myélome

Olivier Decaux, Laurence Lodé, Florence Magrangeas et al. · Journal of Clinical Oncology · 2008 · 367 citations

Gene-expression molecular subtyping of triple-negative breast cancer tumours: importance of immune response

Pascal Jézéquel, Delphine Loussouarn, Catherine Guérin‐Charbonnel et al. · Breast Cancer Research · 2015 · 326 citations · Full text

bc-GenExMiner 4.5: new mining module computes breast cancer differential gene expression analyses

Pascal Jézéquel, Wilfried Gouraud, Fadoua Ben Azzouz et al. · Database · 2021 · 211 citations · Full text